UPDATE: Barclays Upgrades Teva Pharmaceutical Industries Limited to Overweight, Raises PT to $65.00
March 07, 2014 at 11:22 AM EST
On Friday, Barclays upgraded shares of Teva Pharmaceuticals (NASDAQ: TEVA) from Equalweight to Overweight and raised the price target ...
